The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 03, 2012

Filed:

Feb. 14, 2006
Applicants:

Shin-ichiro Nishimura, Sapporo, JP;

Noriko Nagahori, Sapporo, JP;

Tomoki Hamamoto, Choshi, JP;

Kiyoshi Okuyama, Choshi, JP;

Toshitada Noguchi, Choshi, JP;

Inventors:

Shin-Ichiro Nishimura, Sapporo, JP;

Noriko Nagahori, Sapporo, JP;

Tomoki Hamamoto, Choshi, JP;

Kiyoshi Okuyama, Choshi, JP;

Toshitada Noguchi, Choshi, JP;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12P 19/50 (2006.01); C12P 19/52 (2006.01); C12P 19/26 (2006.01); C07H 15/00 (2006.01); C07H 5/04 (2006.01); C07H 5/06 (2006.01); C08B 37/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention is directed to, for example, an oligosaccharide having at an end thereof a 4-position halogenated galactose residue represented by formula (I): (wherein X represents a halogen atom, and R represents a monosaccharide, an oligosaccharide, or a carrier), a transferase inhibitor containing the oligosaccharide, and a method for inhibiting sugar chain elongation reaction in the presence of glycosyltransferase, the method including employing the inhibitor. The invention also provides a method for producing a 4-position halogenated galactose sugar nucleotide represented by formula (II): (wherein each of Rto Rrepresents a hydroxyl group, an acetyl group, a halogen atom, or a hydrogen atom; X represents a halogen atom; and M represents a hydrogen ion or a metal ion), wherein the method employs bacterium-derived galactokinase and bacterium-derived hexose-1-phosphate uridylyltransferase. The invention is also directed to a sugar chain containing 4-position halogenated galactose envisaged to be employed as drugs and other materials, and to applications of the compound.


Find Patent Forward Citations

Loading…